Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSH.L Regulatory News (CSH)

  • There is currently no data for CSH

Form 8.5 (EPT/RI)

22 May 2023 08:55

RNS Number : 1792A
Panmure Gordon (UK) Limited
22 May 2023
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Panmure Gordon (UK) Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Civitas Social Housing plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Civitas Social Housing plc

(d) Date dealing undertaken:

19 May 2023

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

10p Ordinary

Purchase

 

2,010,064

0.7995

 

0.795

 

10p Ordinary

Sales

2,211,857

0.8

 

0.799

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing, or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

22/05/2023

Contact name:

Mohammed Jamal

Telephone number:

020 7886 2780

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERKZGZKNZDGFZG
Date   Source Headline
13th Feb 20194:24 pmRNSHolding(s) in Company
31st Jan 20197:00 amRNSNet Asset Values, Investment and Market Update
25th Jan 20194:39 pmRNSBespoke Supportive Tenancies: Grading Under Review
18th Jan 20193:01 pmRNSDirector/PDMR Shareholding
18th Jan 20192:59 pmRNSDirector/PDMR Shareholding
17th Jan 20195:56 pmRNSDirector/PDMR Shareholding
17th Jan 20195:56 pmRNSDirector/PDMR Shareholding
14th Jan 20193:51 pmRNSHolding(s) in Company
14th Jan 20193:48 pmRNSHolding(s) in Company
2nd Jan 20194:16 pmRNSTotal Voting Rights
24th Dec 201811:45 amRNSHolding(s) in Company
21st Dec 20187:00 amRNSAcquisition
20th Dec 20185:45 pmRNSCivitas Social Housing
20th Dec 20185:29 pmRNSDirector/PDMR Shareholding
20th Dec 20181:28 pmRNSCONVERSION OF C SHARES
5th Dec 20187:00 amRNSUpdate on Westmoreland and the Company's Portfolio
5th Dec 20187:00 amRNSAcquisition
30th Nov 201810:07 amRNSAdviser's Update
29th Nov 20187:00 amRNSDividend Declaration
29th Nov 20187:00 amRNSHalf-year Report
15th Nov 20187:00 amRNSConversion of C Shares
9th Nov 20187:00 amRNSFTSE 250 Index Inclusion
8th Nov 20186:12 pmRNSWoodford Patient Capital Trust
2nd Nov 20187:00 amRNSAcquisition
1st Nov 20187:00 amRNSNet Asset Values, Investment and Market Update
31st Oct 20187:00 amRNSAcquisition
22nd Oct 20187:00 amRNSAcquisition
4th Oct 20187:00 amRNSAcquisition
20th Sep 20185:11 pmRNSHolding(s) in Company
7th Sep 201810:00 amRNSEPRA Index Inclusion
7th Sep 20187:00 amRNSAcquisition
29th Aug 20189:57 amEQSHardman & Co Research: Advanced Oncotherapy (AVO): Treatment planning system agreement
29th Aug 20189:35 amEQSHardman & Co Research: Advanced Oncotherapy (AVO): Treatment planning system agreement
28th Aug 20187:00 amRNSAcquisition
24th Aug 201812:57 pmEQSHardman & Co Research: Civitas Social Housing (CSH): Housing security
22nd Aug 201811:22 amRNS£37.6m acquisition of regulated social housing
9th Aug 201811:48 amRNSHolding(s) in Company
6th Aug 20187:00 amRNSAcquisition
3rd Aug 20187:00 amRNSNet Asset Values, Investment and Market Update
2nd Aug 20186:05 pmRNSResult of AGM
3rd Jul 20187:00 amRNSNotice of AGM
14th Jun 20188:23 amRNS£5.4 million acquisition
13th Jun 201810:04 amRNSInitiation research from QuotedData
12th Jun 20187:00 amRNSAnnual Results
12th Jun 20187:00 amRNSPublication of Independent Social Impact Report
12th Jun 20187:00 amRNS£20m increase in 3-Year Revolving Loan Facility
11th Jun 20187:00 amRNS£500 million Invested into Social Housing
11th Jun 20187:00 amRNSAcquisition
1st Jun 20187:00 amRNSAcquisition
30th May 20189:13 amRNSNet Asset Values, Investment and Market Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.